Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage
- PMID: 25361574
- PMCID: PMC4228158
- DOI: 10.1186/1471-2261-14-153
Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage
Abstract
Background: Obesity is associated with the onset of type 2 diabetes mellitus (T2D), but reports conflict regarding the association between obesity and macrovascular complications. In this study, we investigated associations between cardiovascular risk factors and body mass index (BMI) and glycemic control in non-insulin-treated patients with T2D.
Methods: Authors gathered cross-sectional data from five observational studies performed in Spain. Generalized logit models were used to analyze the relationship between cardiovascular risk factors (independent variables) and 5 BMI strata (<25 kg/m2, 25 to <30 kg/m2, 30 to <35 kg/m2, 35 to <40 kg/m2, ≥40 kg/m2) and 5 glycated hemoglobin (HbA1c) strata (≤6.5%, >6.5-7%, >7-8%, >8-9%, >9%) (dependent outcomes).
Results: In total, data from 6442 patients were analyzed. Patients generally had mean values of investigated cardiovascular risk factors outside recommended thresholds. Younger patients had higher BMI, triglyceride levels and HbA1c than their older counterparts. Diastolic blood pressure, systolic blood pressure and triglyceride levels were directly correlated with BMI strata, whereas an inverse correlation was observed between BMI strata and high-density lipoprotein cholesterol (HDL-C) levels, patient age, and duration of T2D. Increased duration of T2D and total cholesterol levels, and decreased HDL-C levels were associated with a higher HbA1c category. BMI and HbA1c levels were not associated with each other.
Conclusions: As insulin-naïve patients with T2D became more obese, cardiovascular risk factors became more pronounced. Higher BMI was associated with younger age and shorter duration of T2D, consistent with the notion that obesity at an early age may be key to the current T2D epidemic. Glycemic control was independent of BMI but associated with abnormal lipid levels. Further efforts should be done to improve modifiable cardiovascular risk factors.
Figures

Similar articles
-
Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank.PLoS Med. 2020 Jul 28;17(7):e1003209. doi: 10.1371/journal.pmed.1003209. eCollection 2020 Jul. PLoS Med. 2020. PMID: 32722720 Free PMC article.
-
The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.Med Arch. 2019 Jun;73(3):163-168. doi: 10.5455/medarh.2019.73.163-168. Med Arch. 2019. PMID: 31404127 Free PMC article.
-
The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL.Cardiovasc Diabetol. 2017 May 19;16(1):66. doi: 10.1186/s12933-017-0548-0. Cardiovasc Diabetol. 2017. PMID: 28526014 Free PMC article.
-
Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):150-6. doi: 10.1097/MED.0000000000000241. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 26863278 Review.
-
Influence of the intervention of exercise on obese type II diabetes mellitus: A meta-analysis.Prim Care Diabetes. 2016 Jun;10(3):186-201. doi: 10.1016/j.pcd.2015.10.003. Epub 2015 Nov 6. Prim Care Diabetes. 2016. PMID: 26553963 Review.
Cited by
-
Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals.Am J Clin Nutr. 2019 Jul 1;110(1):63-75. doi: 10.1093/ajcn/nqz028. Am J Clin Nutr. 2019. PMID: 31095300 Free PMC article.
-
LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.Cardiovasc Diabetol. 2016 Feb 10;15:29. doi: 10.1186/s12933-016-0341-5. Cardiovasc Diabetol. 2016. PMID: 26864124 Free PMC article. Clinical Trial.
-
Control of diabetes, hypertension, and dyslipidemia in Jordan: a cross-sectional study.Ann Med Surg (Lond). 2023 Mar 24;85(3):439-445. doi: 10.1097/MS9.0000000000000272. eCollection 2023 Mar. Ann Med Surg (Lond). 2023. PMID: 37008178 Free PMC article.
-
Adverse Outcomes in Obese Cardiac Surgery Patients Correlates With Altered Branched-Chain Amino Acid Catabolism in Adipose Tissue and Heart.Front Endocrinol (Lausanne). 2020 Aug 7;11:534. doi: 10.3389/fendo.2020.00534. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32903728 Free PMC article.
-
Mendelian Randomization Analysis Support Causal Associations of HbA1c with Circulating Triglyceride, Total and Low-density Lipoprotein Cholesterol in a Chinese Population.Sci Rep. 2019 Apr 2;9(1):5525. doi: 10.1038/s41598-019-41076-6. Sci Rep. 2019. PMID: 30940890 Free PMC article.
References
-
- Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40. doi: 10.1016/S0140-6736(11)60679-X. - DOI - PubMed
Pre-publication history
-
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2261/14/153/prepub
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials